Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients

NCT02768259 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-07-12

No results posted yet for this study

Summary

* Measuring the incidence and prevalence of PAH in Egyptian patients with different types of MCD
* Determination of survival \& the risk factors of mortality.

Conditions

  • Connective Tissue Diseases
  • Pulmonary Hypertension

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mostafa I Elshazly, MD · Professor of pulmonary Medicine ,Cairo University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02768259 on ClinicalTrials.gov